healthcare
healthcare Articles
Tilray shares got a boost after the cannabis firm released its most recent quarterly results after the markets closed on Monday.
Published:
Last Updated:
Dermira shares more than doubled on Monday after the firm announced midstage results from its Eczema study.
Published:
Last Updated:
PhaseBio shares more than doubled on Monday after the firm released results from an early-stage clinical trial of its antiplatelet reversal agent.
Published:
Last Updated:
Karyopharm shares jumped on Friday after the firm announced an FDA update from the FDA on its treatment for myeloma.
Published:
Last Updated:
Johnson & Johnson shares dipped on Thursday on news that a California jury awarded $29 million to a woman that claimed its talcum-powder-based products caused her cancer.
Published:
Last Updated:
Aurora Cannabis is hoping to work collaboratively with notorious activist investor Nelson Peltz to strategically explore potential partnerships.
shares jumped early on Wednesday after the Cannabis...
Published:
Last Updated:
In a new research report, RBC did some intense digging in the small-cap arena and came up with some fascinating research. These are five top small-cap growth plays suited for aggressive accounts.
Published:
Last Updated:
Patients suffering anemia due to chronic kidney disease are sure to be content with new positive top-line results from two Phase 3 active-controlled pivotal studies.
Published:
Last Updated:
The February 28 short interest data have been compared with the previous figures, and short interest moves in these selected marijuana stocks were mixed.
Published:
Last Updated:
The February 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
Published:
Last Updated:
In an incredible move for adolescent patients 12 to 17 years of age, the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for with moderate-to-severe atopic dermatitis.
Published:
Last Updated:
Tonix Pharma shares made a solid gain on Monday after the firm announced that it is beginning to enroll patients in its late-stage study of Tonmya for the treatment of post-traumatic stress disorder.
Published:
Last Updated:
Axovant Sciences has produced results from two separate studies related to neurodegenerative diseases, and its shares had a sharp gain to start off the week.
Published:
Last Updated:
Tonix Pharma shares spiked on Friday after the firm announced that it received a patent from the European Patent Office for its “Method for Treating Neurodegenerative Dysfunction.”
Published:
Last Updated: